Potential Deleterious Effects of Vasopressin in Chronic Kidney Disease and Particularly Autosomal Dominant Polycystic Kidney Disease

Plasma Copeptin and the Risk of Diabetes Mellitus

(2010) Sofia Enhörning et al.   CIRCULATION

Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease

(2010) E. Meijer et al.   Clinical Journal of the American Society of Nephrology

Vasopressin induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule

(2010) Nis B. Pedersen et al.   KIDNEY INTERNATIONAL

Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats

(2009) Tadashi Okada et al.   Clinical and Experimental Nephrology

Endothelial Markers May Link Kidney Function to Cardiovascular Events in Type 2 Diabetes

(2009) C. Maier et al.   DIABETES CARE

V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin–angiotensin system inhibition in rats with renal mass reduction

(2009) Norberto Perico et al.   KIDNEY INTERNATIONAL

Vasopressin in chronic kidney disease: an elephant in the room?

(2009) Vicente E. Torres   KIDNEY INTERNATIONAL

Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort

(2009) Esther Meijer et al.   KIDNEY INTERNATIONAL

Copeptin, a Surrogate Marker of Vasopressin, Is Associated With Accelerated Renal Function Decline in Renal Transplant Recipients

(2009) Esther Meijer et al.   TRANSPLANTATION

Sodium Excretion in Response to Vasopressin and Selective Vasopressin Receptor Antagonists

(2008) J. Perucca et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells

(2008) Atsuo Tahara et al.   PHARMACOLOGICAL RESEARCH

Copeptin: clinical use of a new biomarker

(2008) Nils G. Morgenthaler et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM